Latest Breaking News On - ரிபேக்க பேந் - Page 5 : comparemela.com

An eight-week gap between the first and second doses of the Pfizer/BioNTech Covid-19 vaccine is a “sweet spot” when it comes to generating strong immune response while protecting the UK population against the Delta variant of coronavirus, scientists have said. In a new study, funded by the Department of Health and Social Care (DHSC), researchers have found that when compared to a four-week gap, a 10-week interval between the doses produces higher antibody levels, as well as a higher proportion of a group of infection-fighting cells in the body known as “helper” T cells. At the start of the second wave of the Covid-19 epidemic, the Joint Committee on Vaccination and Immunisation (JCVI) made a decision to recommend a 12-week gap between two doses for the two vaccines that were available at the time: Pfizer and Oxford/AstraZeneca.

United kingdomOxford astrazenecaRebecca payneBiontech covidSusanna duanchieNadhim zahawiNewcastle universityUniversity of oxfordCommittee on vaccinationDepartment of healthUniversity of liverpoolSocial careJoint committeeLance turtleMinister nadhim zahawiஒன்றுபட்டது கிஂக்டம்